Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

Richard L Rauck1 Carolinas Pain Institute, Winston-Salem, NC, USA, [email protected]Correspondence[email protected]

Neal E Slatkin2 School of Medicine, University of California Riverside, Riverside, CA, USA;3 Medical Affairs, Salix Pharmaceuticals, Bridgewater, NJ, USA

Nancy Stambler4 Clinical Research, Progenics Pharmaceuticals, New York, NY, USA

Robert J Israel3 Medical Affairs, Salix Pharmaceuticals, Bridgewater, NJ, USA

Pages 139-150 | Published online: 24 Dec 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Institute of MedicineReliving Pain in America: A Blueprint For Transforming Prevention, Care, Education, and ResearchWashington, DCThe National Academies Press2011
Google Scholar
GereauRWSlukaKAMaixnerWA pain research agenda for the 21st centuryJ Pain201415121203121425419990
PubMed Web of Science ®Google Scholar
ChouRFanciulloGJFinePGClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
PubMed Web of Science ®Google Scholar
BusseJWCraigieSJuurlinkDNGuideline for opioid therapy and chronic noncancer painCMAJ201718918E659E66628483845
PubMed Web of Science ®Google Scholar
CamilleriMDrossmanDABeckerGWebsterLRDaviesANMaweGMEmerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipationNeurogastroenterol Motil201426101386139525164154
PubMed Web of Science ®Google Scholar
GaertnerJSiemensWCamilleriMDefinitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic reviewJ Clin Gastroenterol201549191625356996
PubMed Web of Science ®Google Scholar
KalsoEEdwardsJEMooreRAMcQuayHJOpioids in chronic non-cancer pain: systematic review of efficacy and safetyPain2004112337238015561393
PubMed Web of Science ®Google Scholar
BellTJPanchalSJMiaskowskiCBolgeSCMilanovaTWilliam-sonRThe prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)Pain Med2009101354218721170
PubMed Web of Science ®Google Scholar
CookSFLanzaLZhouXGastrointestinal side effects in chronic opioid users: results from a population-based surveyAliment Pharmacol Ther200827121224123218363893
PubMed Web of Science ®Google Scholar
NobleMTregearSJTreadwellJRSchoellesKLong-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safetyJ Pain Symptom Manage200835221422818178367
PubMed Web of Science ®Google Scholar
CoyneKSLoCasaleRJDattoCJSextonCCYeomansKTackJOpioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart reviewClinicoecon Outcomes Res2014626928124904217
PubMedGoogle Scholar
NelsonADCamilleriMChronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunitiesTherap Adv Gastroenterol201584206220
PubMed Web of Science ®Google Scholar
MurphyDBSuttonJAPrescottLFMurphyMBOpioid-induced delay in gastric emptying: a peripheral mechanism in humansAnesthesiology19978747657709357876
PubMed Web of Science ®Google Scholar
YuanCSFossJFO’ConnorMMethylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trialJAMA2000283336737210647800
PubMed Web of Science ®Google Scholar
WebsterLRBrennerDMBarrettACPatersonCBorteyEForbesWPAnalysis of opioid-mediated analgesia in phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer painJ Pain Res2015877178026586963
PubMed Web of Science ®Google Scholar
ThomasJKarverSCooneyGAMethylnaltrexone for opioid-induced constipation in advanced illnessN Engl J Med20083282223322343
Web of Science ®Google Scholar
Relistor [package insert]Bridgewater, NJSalix Pharmaceuticals2017
Google Scholar
MichnaEBlonskyERSchulmanSSubcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled studyJ Pain201112555456221429809
PubMed Web of Science ®Google Scholar
ViscusiERBarrettACPatersonCForbesWPEfficacy and safety of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain: a placebo crossover analysisReg Anesth Pain Med2016411939826650429
PubMed Web of Science ®Google Scholar
SiemensWBeckerGMethylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomesTher Clin Risk Manag20161240141227042082
PubMed Web of Science ®Google Scholar
MehtaNO’ConnellKGiambroneGPBaqaiADiwanSEfficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic reviewPostgrad Med2016128328228926839023
PubMed Web of Science ®Google Scholar
RauckRSlatkinNEStamblerNHarperJRIsraelRJRandomized, double-blind trial of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic noncancer painPain Pract201717682082827860208
PubMed Web of Science ®Google Scholar
HandelsmanLCochraneKJAronsonMJNessRRubinsteinKJKanofPDTwo new rating scales for opiate withdrawalAm J Drug Alcohol Abuse19871332933083687892
PubMed Web of Science ®Google Scholar
PergolizziJVRaffaRBPappagalloMPeripherally acting µ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapyPatient Prefer Adherence20171110711928176913
PubMed Web of Science ®Google Scholar
HolzerPOpioid receptors in the gastrointestinal tractRegul Pept20091551–3111719345246
PubMed Web of Science ®Google Scholar
YuanCSFossJFO’ConnorMToledanoARoizenMFMossJMethylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trialClin Pharmacol Ther19965944694758612393
PubMed Web of Science ®Google Scholar
YuanC-SFossJFMethylnaltrexone: Investigation of clinical applicationsDrug Dev Res2000502133141
Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date